journal article·2023-06

Copper Peroxides Based Multiple Tumor Microenvironment Regulation for Enhanced Photodynamic/Chemodynamic Synergistic Therapy

Meifang Wang, Wenyin Zhang, Binbin Ding, Ping'an Ma, Jun Lin

Advanced Optical Materials· Volume 11· Issue 11
Publisher page

Abstract

Abstract Hypoxia, overexpressed glutathione (GSH) and depletable H2O2 in tumor microenvironment (TME) are three major obstacles to the development of reactive oxygen species (ROS)‐mediated antitumor therapy. Herein, a photodynamic/chemodynamic synergistic therapeutic nanoagent, DMOS@CuO2/ICG‐HA (DCI), is synthesized based on copper peroxide (CuO2) and indocyanine green (ICG) co‐loaded disulfide‐bond‐incorporated dendritic mesoporous organosilica (DMOS), with modification of hyaluronic acid (HA). The DCI nanocomposites (NCs) can realize multiple TME regulating ability through releasing H2O2/O2 and depleting GSH under acidic condition. Besides, the released Cu2+ can contribute to T1‐weighted magnetic resonance imaging (MRI) in vitro and in vivo. After accumulating at the tumor sites, the DCI NCs can overcome the hypoxia and produce high level of ROS to induce cell apoptosis upon laser irradiation. Hence, the as‐prepared DCI nanoagent can realize MRI‐guided synergistic photodynamic/chemodynamic therapy with enhanced antitumor efficacy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Cancer, Stress, Anesthesia, and Immune Response

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 P. R. China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (32)

Show source-provided references
1. 10.1002/adma.20190715210.1002/adma.201907152 ↗
2. 10.1002/advs.20200185310.1002/advs.202001853 ↗
3. 10.1038/s41467-021-24961-510.1038/s41467-021-24961-5 ↗
4. 10.1002/adhm.20200124010.1002/adhm.202001240 ↗
5. 10.1002/adma.20210397810.1002/adma.202103978 ↗
6. 10.1021/jacs.8b0107210.1021/jacs.8b01072 ↗
7. 10.1016/j.nantod.2020.10094610.1016/j.nantod.2020.100946 ↗
8. 10.1021/jacs.0c0560410.1021/jacs.0c05604 ↗
9. 10.1002/adma.20210122310.1002/adma.202101223 ↗
10. 10.1038/s41467-018-08234-210.1038/s41467-018-08234-2 ↗
11. 10.1016/j.actbio.2021.11.00710.1016/j.actbio.2021.11.007 ↗
12. 10.1039/D0SC02937H10.1039/D0SC02937H ↗
13. 10.1002/adfm.20190619510.1002/adfm.201906195 ↗
14. 10.1021/acsami.0c1907410.1021/acsami.0c19074 ↗
15. 10.1002/advs.20190213710.1002/advs.201902137 ↗
16. 10.1021/acs.nanolett.0c0004710.1021/acs.nanolett.0c00047 ↗
17. 10.1002/ange.20210925810.1002/ange.202109258 ↗
18. 10.1021/acsami.0c1068510.1021/acsami.0c10685 ↗
19. 10.1002/adfm.20190859810.1002/adfm.201908598 ↗
20. 10.1021/acs.chemmater.9b0089310.1021/acs.chemmater.9b00893 ↗
21. 10.1002/smll.20220353110.1002/smll.202203531 ↗
22. 10.1002/adma.20190527110.1002/adma.201905271 ↗
23. 10.1002/advs.20180173310.1002/advs.201801733 ↗
24. 10.1007/s12274-020-2844-310.1007/s12274-020-2844-3 ↗
25. 10.1016/j.chempr.2019.06.00310.1016/j.chempr.2019.06.003 ↗
26. 10.1016/j.jhazmat.2019.04.05810.1016/j.jhazmat.2019.04.058 ↗
27. 10.7150/thno.3983110.7150/thno.39831 ↗
28. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
29. 10.1002/ange.20190398110.1002/ange.201903981 ↗
30. 10.1021/acsnano.0c1075610.1021/acsnano.0c10756 ↗
31. 10.1002/adhm.20200120510.1002/adhm.202001205 ↗
32. 10.1021/acsnano.1c0789310.1021/acsnano.1c07893 ↗